Ischemia-modified albumin levels predict long-term outcome in patients with acute myocardial infarction. The French Nationwide OPERA study

American Heart Journal

Volumn 159, Issue 4, 2010, Pages 570-576

  Van Belle, Eric ^a   Dallongeville, Jean ^b   Vicaut, Eric ^c   Degrandsart, Alexia ^d   Baulac, Cathrine ^d   Montalescot, Gilles ^e  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c Hopital F VIDAL   (France)

^d PFIZER INC   (United States)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISCHEMIA MODIFIED ALBUMIN; LOW MOLECULAR WEIGHT HEPARIN; NITRATE; THIENOPYRIDINE DERIVATIVE; TROPONIN;

ACUTE HEART INFARCTION; ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HEART ARREST; HEART DEATH; HEART FAILURE; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECORDING; RECURRENT DISEASE; RESUSCITATION; STROKE;

AGED; ALBUMINS; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77950134830     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.12.026     Document Type: Article

References (26)

1. Alpert J.S., Thygesen K., Antman E., et al. Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 36 (2000) 959-969
2. Goodman S.G., Steg P.G., Eagle K.A., et al. The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 151 (2006) 654-660
3. Ottani F., Galvani M., Nicolini F.A., et al. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. Am Heart J 140 (2000) 917-927
4. Heidenreich P.A., Alloggiamento T., Melsop K., et al. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol 38 (2001) 478-485
5. Meier M.A., Al-Badr W.H., Cooper J.V., et al. The new definition of myocardial infarction: diagnostic and prognostic implications in patients with acute coronary syndromes. Arch Intern Med 162 (2002) 1585-1589
6. Pell J.P., Simpson E., Rodger J.C., et al. Impact of changing diagnostic criteria on incidence, management, and outcome of acute myocardial infarction: retrospective cohort study. Bmj 326 (2003) 134-135
7. Rao S.V., Ohman E.M., Granger C.B., et al. Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes. Am J Cardiol 91 (2003) 936-940
8. Granger C.B., Goldberg R.J., Dabbous O., et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 163 (2003) 2345-2353
9. Sinha M.K., Roy D., Gaze D.C., et al. Role of "ischemia modified albumin," a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 21 (2004) 29-34
10. Bar-Or D., Winkler J.V., Vanbenthuysen K., et al. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J 141 (2001) 985-991
11. Cho D.K., Choi J.O., Kim S.H., et al. Ischemia-modified albumin is a highly sensitive serum marker of transient myocardial ischemia induced by coronary vasospasm. Coron Artery Dis 18 (2007) 83-87
12. Sinha M.K., Gaze D.C., Tippins J.R., et al. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 107 (2003) 2403-2405
13. Collinson P.O., Gaze D.C., Bainbridge K., et al. Utility of admission cardiac troponin and "ischemia modified albumin" measurements for rapid evaluation and rule out of suspected acute myocardial infarction in the emergency department. Emerg Med J 23 (2006) 256-261
14. Peacock F., Morris D.L., Anwaruddin S., et al. Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J 152 (2006) 253-262
15. Aparci M., Kardesoglu E., Ozmen N., et al. Prognostic significance of ischemia-modified albumin in patients with acute coronary syndrome. Coron Artery Dis 18 (2007) 367-373
16. Montalescot G., Dallongeville J., Van Belle E., et al. STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry). Eur Heart J 28 (2007) 1409-1417
17. Steyerberg E.W., Harrell Jr. F.E., Borsboom G.J., et al. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 54 (2001) 774-781
18. Bertrand M.E., Simoons M.L., Fox K.A., et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 23 (2002) 1809-1840
19. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 40 (2002) 1366-1374
20. Morrow D.A., Antman E.M., Charlesworth A., et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 102 (2000) 2031-2037
21. Antman E.M., Cohen M., Bernink P.J., et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 284 (2000) 835-842
22. Eagle K.A., Lim M.J., Dabbous O.H., et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 291 (2004) 2727-2733
23. Fox K.A., Dabbous O.H., Goldberg R.J., et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 333 (2006) 1091-1094
24. Ohman E.M., Granger C.B., Harrington R.A., et al. Risk stratification and therapeutic decision making in acute coronary syndromes. JAMA 284 (2000) 876-878
25. Worster A., Devereaux P.J., Heels-Ansdell D., et al. Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ 172 (2005) 1685-1690
26. Sabatine M.S. When prognosis precedes diagnosis: putting the cart before the horse. CMAJ 172 (2005) 1697-1698